Aleos Capital to launch Aleos Fund I with between EUR 150m and EUR 200m to invest in life sciences sector
Aleos Capital lanza Aleos Fund I con entre EUR 150m y EUR 200m para invertir en sector de biociencias
Intel ID : 424572
|
||||
Relevant Documents
| Prospectus (Final) | 02 Oct 2025 | Aleos_Capital_Folleto_2025.pdf | ES |
|
| Intel ID | 424572 | |
| Value | EUR 175,00m | |
| Native Currency | Euro (EUR) | |
| Date |
 |
|
| Country | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Primary Subsector (TTRSC) |
25.01.01 Asset Management (Primary) 25 Financial Services / 25.01 Banking & Investment 25.01.10 Venture Capital (Primary) 25 Financial Services / 25.01 Banking & Investment |
|
| Secondary Subsectors (TTRSC) |
25.01.99 Other Banking & Investment 25 Financial Services / 25.01 Banking & Investment 25.03.02 Real Estate Investment Trusts (REITs) 25 Financial Services / 25.03 Real Estate |
|
| Type |
 |
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
25.01.01 Asset Management 25 Financial Services / 25.01 Banking & Investment |
||
| Secondary Sectors (TTRSC) |
25.01.99 Other Banking & Investment 25 Financial Services / 25.01 Banking & Investment 25.03.02 Real Estate Investment Trusts (REITs) 25 Financial Services / 25.03 Real Estate |
||
| Country |
|
||
| Description |
|
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
25.01.10 Venture Capital 25 Financial Services / 25.01 Banking & Investment |
||
| Country |
|
||
| Description |
|
Legal Advisory
| Parties | Advisor | Type | Notes from Advisors | |||||
|---|---|---|---|---|---|---|---|---|
|
-
- - |
- | - |
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.